Late Effects of Childhood/ AYA Cancer

Learning Objectives:

1. Understand what factors contribute to late effects of cancer therapy and what are the important components to a treatment summary 
2. Know where to locate late effect surveillance guidelines 
3. Learn how to monitor for endocrine, cardiac late effects of cancer therapy 
4. Be aware of recommendations for early cancer screening for at risk cancer survivors 

Dr. Fulbright discloses that she has no relevant financial relationships with any organization producing, marketing, reselling or distributing health care goods or services consumed by or used on patients relative to the content of this presentation. 

The program was planned, implemented and accredited by the Kansas Association of Osteopathic Medicine (KAOM).

The Kansas Association of Osteopathic Medicine is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity. 

Grievance Policy:

KAOM will respond to all grievances in a timely manner and you may call Vicki Whitaker, Executive Director at 785-234-5563 to discuss them. KAOM wants to be made aware of the grievance in order to resolve it to your satisfaction. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response from KAOM they can submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611. 

For questions pertaining to this presentation please email KAOM Executive Director, Vicki Whitaker at vicki@kansasdo.org. Please place CME question in the subject line.